Purpose Medical is my sales/consulting company designed specifically to help with new device technologies and start-up medical device companies.My expertise in commercialization strategies, marketing programs, sales and management consulting, and medical device sales has been a true asset for companies like Endoshape, Roxwood Medical, Brightwater Medical, Avantec Vascular, and others.I am currently looking for vendor partners looking to commercialize their medical device technology in the cardiovascular market. I can help with commercialization strategies, market analysis and development, or purely customer sales in the hospital or outpatient-based lab market.

Responsible for full commercialization strategy for new cardiovascular medical device to be used in Cath Labs and IR Suites across the country. Responsibilities include sales and marketing budget, market research and analysis, commercialization strategy, KOL identification, establisihing Medical Advisory Board, coordinating animal lab research, and assisting with marketing strategy and collateral development.

Responsible for selling Control Medical device, Aspire Mechanical Thrombectomy, in the Florida market.

Responsible for selling the Medusa MultiCoil to physicians in the state of Florida and surrounding geographies.Responsible for engaging physicians in new technology launches and product updates including animal lab participation, design modifications, and device upgrades.

Responsible for conducting limited launch marketing study for the ConvertX Nephroureteral Stent System. Established 4 sites in FL to be included in limited launch and continue using the device through commercialization.

Responsible for the sale of the Roxwood Medical line of products, CenterCross ULTRA and MicroCross, in the SE market.

Responsible for the launch of a new, innovative femoral closure device in the North and Central Florida, and South Georgia markets.Territory manager for large multi-state territory responsible for increasing closure device sales through prospecting new users, clinically training users on closure device, and strengthening and establishing new relationships with experienced and new physicians. Promoted to newly established Senior Territory Manager in June 2014, first Senior Manager in the company.Promoted to Trainer in June 2014 and was responsible for field ride-along assignments with new hires as part of Corporate Training.Consistently ranked in Top 10 VSC (Vascular Closure Specialists) nationwide.

 IDEV is a start-up company offering a very specific, highly clinical product for very specific needs in the Interventional Cardiology, Vascular Surgery, and Interventional Radiology markets. Territory manager for large multi-state territory responsible for increasing interventional product sales through prospecting new users, clinically training users on complex device, and strengthening and establishing new relationships with experienced and new physicians.  Six consecutive quarters above quota; never missed a number during my tenure at IDEV.  2012 – finished year well above quota (140%), finished in Top 10 National Rankings, and received special commendation from Executive Team for revenue production. 2013 – continued track record of success, ranked currently in Top 10 National Rankings. Rebuilt a territory on track to record only $140,000 in annual revenue and produced over $500,000 my first year. On pace for $750,000 revenue for 2013.

 Covered a large multi-state territory responsible for sales in Interventional Radiology, Vascular Surgery, and Cardiovascular specialties.  Developed new business with Vascular Surgeons and Cardiologists in a traditionally, radiology-weighted territory.  2007 – ranked 7 out of 54 reps and had grown my territory almost $300,000.  2008 – ranked 4th out of 57 reps, with over $700,000 and 50% growth. 2008 – achieved President’s Club honors for finishing #4 out of 57 reps and promoted to Regional Trainer for all product categories. October 2008, territory was ranked 7 out of 42 territories

 Covered a large multi-state territory responsible for increasing business in the SharpSafety Division. Converted 4 hospitals to Kendall product in the first 4 months, which resulted in $150,000 of annual revenue.  May 2006, the territory was ranked 2nd in the region and was consistently exceeding quota.